TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05930977

Intervention type: PROCEDURE
Intervention: total thyroidectomy followed by thyroid auto transplantation
Description: All studied cases received general endotracheal anaesthesia, and all underwent total thyroidectomy.~Frozen section will be done intraoperative to exclude malignancy and obtain piece of healthy tissue part .~Most healthy-looking part of gland was selected after complete excision. Thyroid tissue to be transplanted weighed between two and five grammes. This section was finely split into ten-fifteen fragments with scalpel. Small pocket was created in sternomastoid muscle, into which these minor fragments were implanted, and this pocket was closed with absorbable sutures to prevent displacement of implanted fragments and was marked with metallic stables, as well as good hemostasis of thyroid bed and skin was closed with subcuticular sutures using absorbable three-zero Vicryl sutures.
Study: NCT04996524

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: epidural analgesia
Description: Patients recieving epidural analgesia instead of systemic analgesia for acute pain in the intensive care unit
Study: NCT05941000

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-Monitoring of Behavior for Physical Activity
Description: Self-Monitoring of Behavior for Physical Activity: Individuals will receive daily text messages that include the Self-Monitoring behavior change technique message with the goal of self-monitoring the number of steps taken on the prior day relative to their baseline average number of steps.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-Monitoring of Behavior for Physical Activity
Description: Self-Monitoring of Behavior for Physical Activity: Individuals will receive daily text messages that include the Self-Monitoring behavior change technique message with the goal of self-monitoring the number of steps taken on the prior day relative to their baseline average number of steps.
Study: NCT05213676

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Inhaled Nitric Oxide (iNO) use
Description: The center will use iNO per their usual protocol in the initial resuscitation period (defined as birth through stabilization and CDH repair). No center will alter any component of their standard clinical practice guideline or protocol governing CDH care.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: De-implementation of Inhaled Nitric Oxide (iNO) use
Description: The center will stop using iNO in the initial resuscitation period (defined as birth through stabilization and CDH repair).
Study: NCT05960786

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Otoband Experimental
Description: Participants will be randomly assigned to use the Otoband to determine effectiveness in providing temporary relief to symptoms of vertigo.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Otoband Experimental
Description: Participants will be randomly assigned to use the Otoband to determine effectiveness in providing temporary relief to symptoms of vertigo.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Otoband Sham
Description: Participants will be randomly assigned to use the Otoband sham to determine effectiveness in providing temporary relief to symptoms of vertigo.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Otoband Sham
Description: Participants will be randomly assigned to use the Otoband sham to determine effectiveness in providing temporary relief to symptoms of vertigo.
Study: NCT05941000

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Action Planning for Physical Activity
Description: Action Planning for Physical Activity: Individuals will receive daily text messages that include the Action Planning behavior change technique with the goal of planning to take action to walk an extra 1,000 steps relative to their baseline average step count.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Action Planning for Physical Activity
Description: Action Planning for Physical Activity: Individuals will receive daily text messages that include the Action Planning behavior change technique with the goal of planning to take action to walk an extra 1,000 steps relative to their baseline average step count.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-Monitoring of Behavior for Mood
Description: Self-Monitoring of Behavior for Mood: Individuals will receive daily text messages that include the Self-Monitoring behavior change technique message with the goal of self-monitoring their mood on the prior day.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-Monitoring of Behavior for Mood
Description: Self-Monitoring of Behavior for Mood: Individuals will receive daily text messages that include the Self-Monitoring behavior change technique message with the goal of self-monitoring their mood on the prior day.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Action Planning for Mood
Description: Action Planning for Mood: Individuals will receive daily text messages that include the Action Planning behavior change technique with the goal of planning to take action to improve their mood.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Action Planning for Mood
Description: Action Planning for Mood: Individuals will receive daily text messages that include the Action Planning behavior change technique with the goal of planning to take action to improve their mood.
Study: NCT05948319

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Doppler ultrasonography
Description: Doppler study was performed in all cases. perinatal outcomes were evaluated.

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Doppler ultrasonography
Description: Doppler study was performed in all cases. perinatal outcomes were evaluated.
Study: NCT05490498

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Collection of breast milk
Description: Collection of breast milk through a sterilized breastfeeding device. Once the collection is completed, the milk will be transferred to a sterile jar provided in a dedicated survey package for transport to the laboratory.
Study: NCT05505682

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Biological (Male Wolbachia-infected Aedes aegypti)
Description: Releases of male Wolbachia-infected Aedes aegypti mosquitoes
Study: NCT05884268

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Venlafaxine
Description: Patients scheduled for elective LC will receive 150 mg venlafaxine before surgery

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients scheduled for elective LC will receive placebo venlafaxine before surgery
Study: NCT05423145

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: self-administered acupressure
Description: The acupressure intervention is self-administered. The intervention group receives an app that instructs them on how to perform a stimulating acupressure protocol, consisting of six acupoints with four of the acupoints performed on both the left and the right sides of the body for a total of ten points. Each of the ten acupoints is to be stimulated for 3 minutes per point for a total treatment time of 30 minutes daily for 6 weeks.
Study: NCT04936256

Intervention type: DEVICE
Intervention: Clareon
Description: Clareon monofocal intraocular lens (IOL)
Study: NCT04023604

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Controlled diet with beef raised without antibiotics
Description: The controlled diet with beef raised without antibiotics will follow the Dietary Guidelines for American's recommendations. All foods and beverages will be provided during intervention to achieve the desired eating pattern. Beef included in this diet were raised without antibiotics.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Controlled diet with beef produced in conventional systems
Description: The controlled diet with beef raised without antibiotics will follow the Dietary Guidelines for American's recommendations. All foods and beverages will be provided during intervention to achieve the desired eating pattern. Beef included in this diet were raised with antibiotics.
Study: NCT05421091

Intervention type: OTHER
Intervention: Asciminib
Description: Prospective observational study. There is no treatment allocation. Patients prescribed with asciminib are eligible to enroll into this study.
Study: NCT05972876

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Blood flow restriction training
Description: BFR will be achieved using an automatic personalized tourniquet system (MAD-UP, Angers, France) designed to automatically calculate limb occlusion pressure

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Resistance training
Description: Resistance training will be performed without any blood flow restriction
Study: NCT05174897

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: emotional liberation technique
Description: experimental group; The child, to whom an intravenous catheter will be applied, is placed on a stretcher. pain ve score fear will be evaluated before the procedure. Then, the emotional liberation technique (EFT) will be applied for 10 minutes and an intravenous catheter will be applied to evaluate the pain and fear scores during and after the procedure.
Study: NCT05544916

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XC221
Description: 200 mg/day, for 5 days

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 2 tablets/day, for 5 days
Study: NCT06472063

Intervention type: OTHER
Intervention: pre- or perioperative treatment and D2 gastrectomy
Description: pre- or perioperative treatment and D2 gastrectomy
Study: NCT05018130

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Calcaneus Osteotomy (Metallic)
Description: Calcaneus Displacement Osteotomy using two metallic screws

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Calcaneus Osteotomy (Bio-integrative)
Description: Calcaneus Displacement Osteotomy using two bio-integrative screws
Study: NCT05467280

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Online HIIT Intervention
Description: They will be given HIIT exercise video sessions twice a week for 6 months, through a mobile application where they will also be given nutritional and health advice, webinars and challenges.
Study: NCT04944069

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Almonertinib
Description: 110 mg oral once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: 15 mg/kg intravenous on Day 1 of 21 day cycles (every 3 weeks)
Study: NCT05770856

Intervention type: DIAGNOSTIC_TEST
Intervention: Metagenomic sequencing
Description: Samples shall be submitted to high throughput sequencing using both illumine MiSeq and Oxford Nanopore Technologies.
Study: NCT05489510

Intervention type: COMBINATION_PRODUCT
Group type: OTHER
Intervention: Pulsed or continuous lighting
Description: The cross-linking procedures will be performed on an outpatient basis using the PXL Platinum 330 System (UVA light source and riboflavin solution).

Intervention type: COMBINATION_PRODUCT
Group type: OTHER
Intervention: Pulsed or continuous lighting
Description: The cross-linking procedures will be performed on an outpatient basis using the PXL Platinum 330 System (UVA light source and riboflavin solution).
Study: NCT05031806

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: iNexin™ (0.08% aCT1)
Description: 36 eligible subjects will be randomized to Vehicle or one of three concentrations of iNexin™ to be administered bilaterally BID for 15 days (from Visit 2 to the evening of Visit 4). Subjects will be randomized 2:1 for each active concentration to Vehicle.randomized 7:3 for each active concentration to Vehicle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: iNexin™ (0.4% aCT1)
Description: 36 eligible subjects will be randomized to Vehicle or one of three concentrations of iNexin™ to be administered bilaterally BID for 15 days (from Visit 2 to the evening of Visit 4). Subjects will be randomized 2:1 for each active concentration to Vehicle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: iNexin™ (2.0% aCT1)
Description: 36 eligible subjects will be randomized to Vehicle or one of three concentrations of iNexin™ to be administered bilaterally BID for 15 days (from Visit 2 to the evening of Visit 4). Subjects will be randomized 2:1 for each active concentration to Vehicle.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle (eye drop formulation without aCT1)
Description: 36 eligible subjects will be randomized to Vehicle or one of three concentrations of iNexin™ to be administered bilaterally BID for 15 days (from Visit 2 to the evening of Visit 4). Subjects will be randomized 2:1 for each active concentration to Vehicle.~During a 7-day study run-in period prior to randomization, all subjects will receive Vehicle eye drops (Vehicle) bilaterally BID (from Visit 1 to the evening before Visit 2).
Study: NCT04933968

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: ALVR106
Description: Infusion, visually identical to placebo

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Infusion, visually identical to ALVR106
Study: NCT05228938

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: VNOTES
Description: vaginal Natural Orifice Transluminal Endoscopic Surgery approach for Elective bilateral salpingectomy or Salpingo-oophorectomy

Intervention type: PROCEDURE
Group type: OTHER
Intervention: laparoscopic
Description: laparoscopic Surgery approach for Elective bilateral salpingectomy or Salpingo-oophorectomy
Study: NCT05748236

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lamotrigine tablet
Description: Lamotrigine: Starting dose 25mg once daily for 2 weeks, then 50 mg once daily for next 2 weeks . Then dose will be increased until seizure control or side effects develop (Maximum 500 mg/day).

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carbamazepine-Containing Product in Oral Dose Form
Description: Starting dose 100mg twice daily for 2 weeks, then 200 mg twice daily for next 2 weeks. Then dose will be increased until seizure control or side effects develop (Maximum 1600 mg/day).
Study: NCT06087029

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: TEVAR
Description: Thoracic endovascular aortic repair

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Guideline directed medical therapy and surveillance of dissection
Description: Routine clinical care with suggested antihypertensive therapy and cardiovascular risk factor reduction as per appropriate cardiovascular guidelines.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Guideline directed medical therapy and surveillance of dissection
Description: Routine clinical care with suggested antihypertensive therapy and cardiovascular risk factor reduction as per appropriate cardiovascular guidelines.
Study: NCT05364125

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Olfactory Training
Description: Four aromatic substances will be used (Citrus limon, Eucalyptus radiata, Pelargonium graveolens, Juniperus virginiana)

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Normal Saline will be used
Study: NCT05243836

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: S.T.O.P® F2
Description: Ocufilcon D, 55% water

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: S.T.O.P® DT
Description: Ocufilcon D, 55% water

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: MiSight®
Description: Omafilcon A (60% water)
Study: NCT06115213

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Patient counselling
Description: Patient counseling, lifestyle modifications, medication evaluation, and adherence
Study: NCT05930457

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 2.5-3.5mCi 64Cu-FAPI-XT117
Description: 64Cu-FAPI-XT117 and 18F-FDG PET/CT were performed for each patient(the interval was more than one day and less than four weeks). PET/CT images were acquired 30min, 60min, 120min after 2.5-3.5mCi 64Cu-FAPI-XT117 injection.
Study: NCT05564936

Intervention type: DEVICE
Group type: OTHER
Intervention: ME&MG mobile application
Description: ME\&MG is a standalone software (digital solution) running on patients smartphones, connected to a web portal for physicians. It is intended to be used as an unsupervised digital self-assessment tool for the monitoring of disabilities in patients living with MG.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ME&MG mobile application
Description: ME\&MG is a standalone software (digital solution) running on patients smartphones, connected to a web portal for physicians. It is intended to be used as an unsupervised digital self-assessment tool for the monitoring of disabilities in patients living with MG.
Study: NCT05450731

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 12-week supervised exercise based cardiac rehabilitation program
Description: 12-week exercise-based cardiac rehabilitation intervention on the recurrence of atrial fibrillation (AF) in patients at six- and twelve-months post-ablation procedure.
Study: NCT05890846

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: active iTBS
Description: Each participant will receive 1800 pulse active iTBS (100% RMT) in each session, 3 sessions per day, 5 days per week for 12 weeks.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham iTBS
Description: Each participant will receive 1800 pulse sham iTBS (100% RMT) in each session, 3 sessions per day, 5 days per week for 12 weeks.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: traditional 1on1 course
Description: Between every two iTBS sessions, the participant will receive a personalized 30-minutes one-on-one behavioral course, 2 courses per day, 5 days per week for 12 weeks.

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: traditional 1on1 course
Description: Between every two iTBS sessions, the participant will receive a personalized 30-minutes one-on-one behavioral course, 2 courses per day, 5 days per week for 12 weeks.
Study: NCT06063824

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Single-Session Method of Levels Intervention
Description: This is a single session of method of levels psychotherapy delivered to patients of GP surgeries in primary care.
Study: NCT05930457

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 3.5-4.5mCi 64Cu-FAPI-XT117
Description: 64Cu-FAPI-XT117 and 18F-FDG PET/CT were performed for each patient(the interval was more than one day and less than four weeks). PET/CT images were acquired 30min, 60min, 120min after 3.5-4.5mCi 64Cu-FAPI-XT117 injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 4.5-5.5mCi 64Cu-FAPI-XT117
Description: 64Cu-FAPI-XT117 and 18F-FDG PET/CT were performed for each patient(the interval was more than one day and less than four weeks). PET/CT images were acquired 30min, 60min, 120min after 4.5-5.5mCi 64Cu-FAPI-XT117 injection.
Study: NCT05841641

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laser Bandage
Description: The Diode Laser will create a biological bandage at a wavelength of 810 nm, set at 5W in continuous-wave mode, applied via a 400-µm optical fibre.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hemostatic agent with surgical stent
Description: Following graft harvesting, the donor site was secured with a hemostatic agent and protected with a palatal stent
Study: NCT04737954

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Venepuncture
Description: Venous blood draw

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Fingerstick
Description: Capillary blood draw
Study: NCT06139939

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Double layer technique
Description: Double layer technique for alveolar ridge augmentation (first layer autograft followed by xenograft second layer).

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Double layer technique
Description: Double layer technique for alveolar ridge augmentation (first layer autograft followed by xenograft second layer).
Study: NCT04970433

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Description: Acupuncture at Hegu (LI4), Neiguan (PC6), Zusanli (ST36), Sanyinjiao (SP6) and Sishencong (EX-HN1). Electrical stimulation with a pair of electrodes connecting on LI4/PC6 and ST36/SP6.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laser acupuncture (LA)
Description: The laser applies to each point for 40 seconds, which delivers 3 J of energy at each of the acupoints as those in electroacupuncture group.

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham laser acupuncture (SLA)
Description: The laser device without any laser output applies on the acupoints the same as those in the LA group.
Study: NCT05498779

Intervention type: PROCEDURE
Intervention: Ablation therapy
Description: Radiofrequency or microwave ablation
Study: NCT06633822

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Digital planning
Description: The digital methodology will consist of obtaining a digital scan and a computed tomography (CBCT) that will be aligned using a digital program for the elaboration of a digital wax-up and fabrication of a printed surgical template.

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Analogic planning
Description: The analog wax-up will be elaborated based on a silicone impression and periapical radiographs with parallel technique, which will allow us to elaborate an essix-type surgical splint.
Study: NCT06431087

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mindfulness course
Description: Online or in presence Information on Mindfulness, healthy diet and exercise.
Study: NCT05847920

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-2010 Injection
Description: SHR-2010 Injection

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT04853212

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biopsy
Description: Biopsy during recto-coloscopy

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Biopsy
Description: Biopsy during recto-coloscopy
Study: NCT05956496

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Allograft Material ADM-S
Description: A piece of the allograft material (ADM-D) will be hydrated per the manufacturers guidelines and adapted to the recipient area after reflection of a partial thickness flap. The flap will be coronally advanced to completely cover the graft material per standard care for this procedure.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Allograft Material ADM-D
Description: A piece of the allograft material (ADM-S) will be hydrated per the manufacturers guidelines and adapted to the recipient area after reflection of a partial thickness flap. The flap will be coronally advanced to completely cover the graft material per standard care for this procedure.